Kamada (KMDA) Non-cash Items (2020 - 2026)
Kamada (KMDA) posted quarterly Non-cash Items of $7.5 million for Q1 2026, down 1.6% year-on-year from $7.6 million in Q1 2025, and up 72.88% on a QoQ basis from $4.3 million in Q4 2025.
Kamada (KMDA) Non-cash Items (2020 - 2026) Analysis & Trends
Kamada (KMDA) has reported Non-cash Items for 7 consecutive years, with $7.5 million the latest figure, recorded in Q1 2026.
- Quarterly Non-cash Items fell 1.6% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 4.21% YoY) and the FY2025 annual result came in at $22.0 million, up 8.06% from the prior year.
- Non-cash Items climbed to $7.5 million in Q1 2026 per KMDA's latest filing, from $4.3 million in the prior quarter.
- Over the last five years, Non-cash Items for KMDA reached as high as $20.0 million in Q4 2022 and fell as low as -$32.6 million in Q4 2023.
- A 5-year average of $3.3 million and a median of $4.9 million in 2024 frame the typical range for Non-cash Items.
- Annual changes were most pronounced in 2023 — Non-cash Items slumped 262.53% — and 2024, when it jumped 91730.18%.
- Year by year, Non-cash Items stood at $20.0 million in 2022, then sank by 262.53% to -$32.6 million in 2023, then surged by 117.17% to $5.6 million in 2024, then retreated by 22.36% to $4.3 million in 2025, then surged by 72.88% to $7.5 million in 2026.
- According to Business Quant data, Non-cash Items over the past three periods registered $7.5 million, $4.3 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 7.63 Mn |
| Mar 31, 2025 | 7.63 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Dec 31, 2023 | -32.56 Mn |
| Dec 31, 2023 | -32.56 Mn |